KEAP1
Kelch-like ECH-associated protein 1
Also known as: INrf2, KEAP1_HUMAN, KIAA0132, KLHL19, MGC10630, MGC1114, MGC20887, MGC4407, MGC9454
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q14145
- Gene
- KEAP1
- Ensembl
- ENSG00000079999
- Chromosome
- 19
- Canonical length
- 624 aa
- Protein class
- Cancer-related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Centriolar satellite,Cytosol
OverviewNCBI Gene
This gene encodes a protein containing KELCH-1 like domains, as well as a BTB/POZ domain. Kelch-like ECH-associated protein 1 interacts with NF-E2-related factor 2 in a redox-sensitive manner and the dissociation of the proteins in the cytoplasm is followed by transportation of NF-E2-related factor 2 to the nucleus. This interaction results in the expression of the catalytic subunit of gamma-glutamylcysteine synthetase. Two alternatively spliced transcript variants encoding the same isoform have been found for this gene. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
624 residues, UniProt reviewed canonical sequence.
>Q14145|KEAP1
1 MQPDPRPSGA GACCRFLPLQ SQCPEGAGDA VMYASTECKA EVTPSQHGNR TFSYTLEDHT
61 KQAFGIMNEL RLSQQLCDVT LQVKYQDAPA AQFMAHKVVL ASSSPVFKAM FTNGLREQGM
121 EVVSIEGIHP KVMERLIEFA YTASISMGEK CVLHVMNGAV MYQIDSVVRA CSDFLVQQLD
181 PSNAIGIANF AEQIGCVELH QRAREYIYMH FGEVAKQEEF FNLSHCQLVT LISRDDLNVR
241 CESEVFHACI NWVKYDCEQR RFYVQALLRA VRCHSLTPNF LQMQLQKCEI LQSDSRCKDY
301 LVKIFEELTL HKPTQVMPCR APKVGRLIYT AGGYFRQSLS YLEAYNPSDG TWLRLADLQV
361 PRSGLAGCVV GGLLYAVGGR NNSPDGNTDS SALDCYNPMT NQWSPCAPMS VPRNRIGVGV
421 IDGHIYAVGG SHGCIHHNSV ERYEPERDEW HLVAPMLTRR IGVGVAVLNR LLYAVGGFDG
481 TNRLNSAECY YPERNEWRMI TAMNTIRSGA GVCVLHNCIY AAGGYDGQDQ LNSVERYDVE
541 TETWTFVAPM KHRRSALGIT VHQGRIYVLG GYDGHTFLDS VECYDPDTDT WSEVTRMTSG
601 RSGVGVAVTM EPCRKQIDQQ NCTCLocalizationUniProt · AlphaFold · HPA
Whether an antibody against KEAP1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.28
- Highest tissue expression
- 171 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 171 nTPM
- tongue: 71 nTPM
- liver: 59 nTPM
- heart muscle: 58 nTPM
- esophagus: 54 nTPM
- spinal cord: 52 nTPM
Single-cell type
- esophageal apical cells: 85 nCPM
- esophageal basal cells: 78 nCPM
- late spermatids: 78 nCPM
- megakaryocytes: 74 nCPM
- esophageal suprabasal cells: 63 nCPM
- thymic myoid cells: 57 nCPM
Immune cell
- gdT-cell: 55 nTPM
- MAIT T-cell: 53 nTPM
- memory CD8 T-cell: 52 nTPM
- T-reg: 50 nTPM
- myeloid DC: 46 nTPM
- NK-cell: 43 nTPM
Brain region
- white matter: 67 nTPM
- cerebellum: 56 nTPM
- medulla oblongata: 56 nTPM
- basal ganglia: 55 nTPM
- midbrain: 53 nTPM
- pons: 52 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.63
- gnomAD pLI
- 0
- gnomAD missense Z
- 3.8
- DepMap mean gene effect
- -0.26
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 8% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cellular response to interleukin-4
- cellular response to oxidative stress
- in utero embryonic development
- negative regulation of response to oxidative stress
- negative regulation of transcription by RNA polymerase II
- positive regulation of proteasomal ubiquitin-dependent protein catabolic process
- proteasome-mediated ubiquitin-dependent protein catabolic process
- protein ubiquitination
- regulation of autophagy
- regulation of epidermal cell differentiation
- ubiquitin-dependent protein catabolic process
Molecular functions
- disordered domain specific binding
- identical protein binding
- RNA polymerase II-specific DNA-binding transcription factor binding
- transcription regulator inhibitor activity
- ubiquitin-like ligase-substrate adaptor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- BTB/POZ domain
- Kelch repeat type 1
- SKP1/BTB/POZ domain superfamily
- BTB/Kelch-associated
- Kelch-type beta-propeller
- BTB-kelch protein
- BTB/POZ domain
- Kelch motif
- BTB And C-terminal Kelch
- KLHDC2/KLHL20/DRC7 Kelch-repeats domain
- Kelch-like ECH-associated protein 1, BTB/POZ domain
- Kelch-like ECH-associated protein 1, BACK domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of KEAP1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads KEAP1 as an antibody target. Whether an autoantibody or antibody against KEAP1 could matter depends on whether native KEAP1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
KEAP1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label KEAP1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...